Handelsavisen
prelaunch
Companies Healthcare BVC.L
BV
BVC.L London Stock Exchange Biotechnology & Medical Research

Bvc.L

$12,80
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
10,9 %
ROE
-28,0 %
Net margin
-14,9 %
Debt / equity
0,16
Beta
52w range
Volume
127
Day range
$9,27–$11,74
Prev close
$10,00
Open
$10,09
Next earnings
2026-08-09
Ex-dividend
TR 1Y
About

BVC.L operates in the biotechnology and medical research sector, focusing on pharmaceuticals and medical research activities.

Business. BitVentures Ltd (BVC.O) is a financial technology company operating in the blockchain and cryptocurrency industry. The firm generates revenue through a fee-income model, focusing on activities within the fintech and infrastructure sector. BitVentures is headquartered in an unspecified location and is primarily listed on the NASDAQ exchange. Specific details regarding operating segments and geographic breakdowns are not available.

Classification92 %
SectorHealthcare
Business sectorPharmaceuticals & Medical Research
IndustryBiotechnology & Medical Research
ActivityPharmaceuticals & Medical Research
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-28,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BVC.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BVC.L. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-08-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    BitVentures Ltd (BVC.O) is a financial technology company operating in the blockchain and cryptocurrency industry. The firm generates revenue through a fee-income model, focusing on activities within the fintech and infrastructure sector. BitVentures is headquartered in an unspecified location and is primarily listed on the NASDAQ exchange. Specific details regarding operating segments and geographic breakdowns are not available.

    Classification92 %
    SectorHealthcare
    Business sectorPharmaceuticals & Medical Research
    IndustryBiotechnology & Medical Research
    ActivityPharmaceuticals & Medical Research
    AI synthesis
    GENERATED

    BVC.L has a liquidity position characterized by a current ratio of 1.85, indicating the company can cover its short-term liabilities with its short-term assets. The company holds cash and equivalents of 22,859,000 USD, which is a positive liquidity indicator. However, the operating cash flow is negative at -6,965,000 USD, suggesting that the company's core operations are not generating positive cash flow. The free cash flow is positive at 6,518,000 USD, indicating that the company has some flexibility in its cash management.

    In terms of profitability, BVC.L has a return on equity of -0.2796 and a return on assets of -0.1611, both of which are negative, indicating that the company is not generating returns for its shareholders or effectively utilizing its assets. The net income is -18,335,000 USD, which is a significant loss, and the operating income is 13,477,000 USD, showing that the company is not profitable overall. The gross profit is 40,064,000 USD, which is a positive figure, but it is not sufficient to offset the company's other expenses.

    The company's capital structure is reflected in a debt-to-equity ratio of 0.16, indicating that the company is not heavily leveraged. The total liabilities are 48,261,000 USD, while the total equity is 65,567,000 USD, suggesting that the company is primarily financed through equity. The long-term debt is 10,357,000 USD, which is relatively low compared to the total equity.

    BVC.L's revenue is 123,198,000 USD, and the company's capital expenditure is -4,282,000 USD, indicating that the company is not investing heavily in new assets. The company's growth trajectory is uncertain, as the net income is negative, and the operating cash flow is also negative. The company's revenue is not growing, and the company is not generating positive cash flow from its operations.

    The risk assessment for BVC.L indicates a low liquidity risk and a low dilution risk. There are no immediate filing-based liquidity or dilution flags, suggesting that the company is not facing any immediate financial distress. The company's capital structure is not heavily leveraged, and the company has a positive free cash flow, which provides some financial flexibility.

    Recent events for BVC.L include the latest financial results, which show a net loss of 18,335,000 USD and a negative operating cash flow of 6,965,000 USD. The company's revenue is 123,198,000 USD, and the company's capital expenditure is -4,282,000 USD. The company's financial performance is not meeting analyst expectations, as the mean EPS estimate is 0.00 USD, while the last actual EPS is -3.94 USD.

    Key takeaways
    • BVC.L has a negative net income of 18,335,000 USD, indicating that the company is not profitable.
    • The company's return on equity is -0.2796, and the return on assets is -0.1611, both of which are negative.
    • BVC.L has a current ratio of 1.85, indicating that the company can cover its short-term liabilities with its short-term assets.
    • The company's liquidity risk is low, and there are no immediate filing-based liquidity or dilution flags.
    • BVC.L's revenue is 123,198,000 USD, and the company's capital expenditure is -4,282,000 USD.
    • The company's financial performance is not meeting analyst expectations, as the mean EPS estimate is 0.00 USD, while the last actual EPS is -3.94 USD.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $12,80
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $65.6M
    Net cash
    $12.5M
    Current ratio
    1.9
    Debt / equity
    0.2
    ROA
    -16.1%
    ROE
    -28.0%
    Cash conversion
    38.0%
    CapEx / revenue
    -3.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Operating income · consensus-800,000 USD
    Revenue surprise
    +29,5 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin10,9 %Above P75
    Net Margin-14,9 %Above median
    ROE-28,0 %Below median
    Capex / Rev-3,5 %Above median
    D/E0,16Below median
    Cash Conv0,38Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • BVC.L Market data — financials · 2026-05-27
    • Batm Advanced Communications Ltd Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Leadership

    • Moti NagarChief Executive Officer, Executive Director

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $02 insiders · last 365d
    • Chen Jie (Janet)Director · Ordinary SharesOther 1 083 · 2026-05-11
    • Gallo Joel AdalbertoDirector · Ordinary SharesOther 1 083 · 2026-05-11

    Short positioning

    4.8Kshares short-22.6% vs prior
    1days to cover
    14.2%short of daily vol
    91fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BVC.LCanonical
    London Stock Exchange · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • Revenue (YoY) (2025-06-30 vs 2024-06-30): -100.0%Derived (calculated)
    • EPS (basic) (YoY) (2025-06-30 vs 2024-06-30): -500.0%Derived (calculated)
    • Operating income (YoY) (2025-06-30 vs 2024-06-30): -376.1%Derived (calculated)
    • Operating cash flow (YoY) (2025-06-30 vs 2024-06-30): -352.8%Derived (calculated)
    • Net income (YoY) (2025-06-30 vs 2024-06-30): -622.6%Derived (calculated)
    • EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): -500.0%Derived (calculated)
    • Revenue (annual): USD 0SEC XBRL filing
    • Net income (annual): USD -5.37MSEC XBRL filing
    • Operating income (annual): USD -3.69MSEC XBRL filing
    • Capex (annual): USD 2KSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Pre-tax income (annual): USD -5.67MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Operating cash flow (annual): USD -6.48MSEC XBRL filing
    • Net income (YoY) (2024-06-30 vs 2023-06-30): 78.6%Derived (calculated)
    • Net margin (FY 2024-06-30): -3.4%Derived (calculated)
    • Operating cash flow (YoY) (2024-06-30 vs 2023-06-30): -72.9%Derived (calculated)
    • Operating income (YoY) (2024-06-30 vs 2023-06-30): 76.8%Derived (calculated)
    • Revenue (YoY) (2024-06-30 vs 2023-06-30): 43.0%Derived (calculated)
    • EPS (basic) (YoY) (2024-06-30 vs 2023-06-30): 83.3%Derived (calculated)
    • EPS (diluted) (YoY) (2024-06-30 vs 2023-06-30): 83.3%Derived (calculated)
    • Revenue (annual): USD 21.82MSEC XBRL filing
    • Operating income (annual): USD -774KSEC XBRL filing
    • Net income (annual): USD -743KSEC XBRL filing
    Showing 24 of 57 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-16FILINGFORM 6-K →
    2026-05-11 00:00 UTCINSIDER2 insider transactions — 2026-05
    2026-05-11INSIDERChen Jie (Janet) transacted 1.1k sh Ordinary Shares — Director
    2026-05-11INSIDERGallo Joel Adalberto transacted 1.1k sh Ordinary Shares — Director
    2026-04-20FILINGFORM 6-K →
    2026-01-07FILINGFORM 6-K →
    2026-01-02FILINGFORM 6-K →
    2025-12-30FILINGFORM 6-K →
    2025-12-23FILINGFORM 6-K →
    2025-12-22FILINGFORM 424B3 →
    2025-12-19FILINGFORM 6-K →
    2025-12-02FILINGFORM 6-K →
    2025-11-05FILINGFORM 6-K →
    2025-10-17FILINGFORM 20-F →
    2025-09-29FILINGFORM 6-K →
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage